About Us
Research
Platforms
Become A Member
News & Events
Contact Us

The Mental Health Australia General Clinical Trials Network

About Us
Research
Platforms
Become A Member
News & Events
Contact Us

Login

MAGNET > Myalgic Encephalomyelitis

TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial

The Mental Health Australia General Clinical Trials Network

Important

Disclaimer
Privacy Policy

Membership

We welcome anyone interested in investigator-led mental health clinical trial research that supports MAGNET’s mission and vision.

Newsletter

Subscribe to our newsletter and be the first to hear about MAGNET events and our updates.

You don’t need to be a member to subscribe!

Email

CAPTCHA

Contact Us

+61 3 4215 3320
magnet@deakin.edu.au

MAGNET acknowledges the traditional custodians of the lands throughout Australia. We pay our respects to their clans, and to the elders, past present and emerging, and acknowledge their continuing connection to land, sea and community.

MAGNET is committed to embracing diversity. MAGNET welcomes all people irrespective of ethnicity, lifestyle choice, faith, sexual orientation and gender identity.

MAGNET is committed to co-design and acknowledges the individual and collective contributions of those with a lived and living experience of mental ill-health and those who care for them.

Mental Health Australia General Clinical Trial Network – MAGNET is supported by a 2020 MRFF Million Minds Mission MHR grant (MRF2006296).